Increased sclerostin levels after further ablation of remnant estrogen by aromatase inhibitors.

Kim W, Chung Y, Kim SH, Park S, Bae JH, Kim G, Lee SJ, Kim JE, Park BW, Lim SK, Rhee Y

DOI: 10.3803/enm.2015.30.1.58
Published: 2015 Mar 27
Container: Endocrinology and metabolism (Seoul, Korea)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3803/enm.2015.30.1.58,
  title = {Increased sclerostin levels after further ablation of remnant estrogen by aromatase inhibitors.},
  author = {Kim W and Chung Y and Kim SH and Park S and Bae JH and Kim G and Lee SJ and Kim JE and Park BW and Lim SK and Rhee Y},
  year = {2015},
  journal = {Endocrinology and metabolism (Seoul, Korea)},
  doi = {10.3803/enm.2015.30.1.58},
  url = {https://doi.org/10.3803/enm.2015.30.1.58}
}

RIS

TY  - JOUR
TI  - Increased sclerostin levels after further ablation of remnant estrogen by aromatase inhibitors.
AU  - Kim W
AU  - Chung Y
AU  - Kim SH
AU  - Park S
AU  - Bae JH
AU  - Kim G
AU  - Lee SJ
AU  - Kim JE
AU  - Park BW
AU  - Lim SK
AU  - Rhee Y
PY  - 2015
JO  - Endocrinology and metabolism (Seoul, Korea)
DO  - 10.3803/enm.2015.30.1.58
UR  - https://doi.org/10.3803/enm.2015.30.1.58
ER  -

APA

W, K., Y, C., SH, K., S, P., JH, B., G, K., SJ, L., JE, K., BW, P., SK, L., & Y, R. (2015). Increased sclerostin levels after further ablation of remnant estrogen by aromatase inhibitors.. Endocrinology and metabolism (Seoul, Korea). https://doi.org/10.3803/enm.2015.30.1.58

Source records

pubmed · retrieved 2026-09-25T08:36:21.528Z